British Journal of Anaesthesia, Vol 76, Issue 1 154-155, Copyright © 1996 by The Board of Management and Trustees of the British Journal of Anaesthesia
H. Teiria, P. Rautoma and A. Yli-Hankala
We have compared the potency of vecuronium given to 12 smokers and 12
non-smokers during propofol-alfentanil-nitrous oxide anaesthesia. After
obtaining individual dose-response curves, bolus doses of vecuronium were
given to maintain neuromuscular block at 90-98% for 60 min. Adductor
pollicis EMG was used to monitor neuromuscular block. Mean ED95 values were
61.38 micrograms kg-1 and 47.49 micrograms kg-1 for smokers and
non-smokers, respectively (P < 0.01). The dose of vecuronium to maintain
90-98% neuromuscular block was 25% higher in smokers than in non-smokers
(96.80 vs 72.11 micrograms kg-1 h-1; P < 0.01). These data reflect the
effects of smoking on neuromuscular block induced by vecuronium. The effect
may be at the receptor level, although possible increased metabolism of
vecuronium in smokers cannot be excluded.
SHORT COMMUNICATIONS
Effect of smoking on dose requirements for vecuronium
Department of Anaesthesia, Helsinki University Central Hospital, Haartmaninkatu 4, FIN-00290 Helsinki, Finland
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Theadom and M. Cropley Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob. Control, October 1, 2006; 15(5): 352 - 358. [Abstract] [Full Text] [PDF] |
||||
